New Target Receptors for Cannabinoids: GPR55 and GPR18

Mary E. Abood, PhD

$29.99


Certificate of participation available upon completion.

You Will Learn About

  • The endogenous cannabinoid system and the endogenous ligands
  • The potential for these receptors playing a physiological role in the central nervous system

What is the evidence for additional cannabinoid receptors and what might they do? Dr. Abood takes learners through a close look at the endogenous cannabinoid system and the endogenous ligands that have been identified. Through a review of the receptor molecular structure and agonist/antagonist screens, the learner will see the potential for these receptors playing a physiological role in the central nervous system.

Purchase of this medical cannabis education course grants one learner one year’s access to lessons and quizzes (access expires 365 days from date of course activation).

Mary E. Abood, PhD

aboodDepartment of Anatomy and Cell Biology, Center for Substance Abuse Research, Temple University

Dr. Abood’s laboratory is investigating recently discovered endogenous compounds called the endocannabinoids and their cellular receptors. The endocannabinoid system is thought to play a role in addiction, pain control, motor control, learning, and memory as well as in regulating immune function and bone growth. Her lab has cloned the CB1 and CB2 receptors and identified some of the structural and concomitant functional features of these receptor molecules. These studies are designed to elucidate the molecular mechanisms of CB receptor action.